New trial in Glioblastoma – step forward in the battle against an aggressive and incurable disease
13 Dec 2018
The EORTC Brain Tumor Group and Protagen AG announce their collaboration to investigate the immuno-competence of long-term Glioblastoma survivors
4 Dec 2018
Interim Results of the CATNON Study – the Effects of Temozolomide
31 Aug 2017
Tackling brain tumours – EORTC proves value of academic collaboration in the research of brain cancer
4 Apr 2017
EORTC helps improve standard of care for brain cancer patients
14 Jun 2016
Combination of Bevacizumab and Lomustine with First Recurrence of Glioblastoma Prolongs PFS but not OS
22 Nov 2015
Enrollment of first patient in a Phase II trabectedin study in brain tumor type called meningioma
21 Sep 2015
Improving treatment for patients with recurrent glioblastoma
18 Feb 2015